Cohort Profile: The Ovarian Cancer Cohort Consortium (OC3)

Mary K Townsend; Britton Trabert; Renée T Fortner; Alan A Arslan; Julie E Buring; Brian D Carter; Graham G Giles; Sarah R Irvin; Michael E Jones; Rudolf Kaaks; Victoria A Kirsh; Synnove F Knutsen; Woon-Puay Koh; James V Lacey; Hilde Langseth; Susanna C Larsson; I-Min Lee; María Elena Martínez; Melissa A Merritt; Roger L Milne; Katie M O'Brien; Michael J Orlich; Julie R Palmer; Alpa V Patel; Ulrike Peters; Jenny N Poynter; Kim Robien; Thomas E Rohan; Lynn Rosenberg; Sven Sandin; Dale P Sandler; Leo J Schouten; V Wendy Setiawan; Anthony J Swerdlow; Giske Ursin; Piet A van den Brandt; Kala Visvanathan; Elisabete Weiderpass; Alicja Wolk; Jian-Min Yuan; Anne Zeleniuch-Jacquotte; Shelley S Tworoger; Nicolas Wentzensen

doi:10.1093/ije/dyab211

Cohort Profile: The Ovarian Cancer Cohort Consortium (OC3)

Mary K Townsend
, Britton Trabert
, Renée T Fortner
, Alan A Arslan
, Julie E Buring
, Brian D Carter
, Graham G Giles
, Sarah R Irvin
, Michael E Jones
, Rudolf Kaaks
, Victoria A Kirsh
, Synnove F Knutsen
, Woon-Puay Koh
, James V Lacey
, Hilde Langseth
, Susanna C Larsson
, I-Min Lee
, María Elena Martínez
, Melissa A Merritt
, Roger L Milne

Katie M O'Brien, Michael J Orlich, Julie R Palmer, Alpa V Patel, Ulrike Peters, Jenny N Poynter, Kim Robien, Thomas E Rohan, Lynn Rosenberg, Sven Sandin, Dale P Sandler, Leo J Schouten, V Wendy Setiawan, Anthony J Swerdlow, Giske Ursin, Piet A van den Brandt, Kala Visvanathan, Elisabete Weiderpass, Alicja Wolk, Jian-Min Yuan, Anne Zeleniuch-Jacquotte, Shelley S Tworoger, Nicolas Wentzensen^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

96 Downloads (Pure)

Original language	English
Pages (from-to)	E73-E86
Number of pages	14
Journal	International Journal of Epidemiology
Volume	51
Issue number	3
Early online date	15 Oct 2021
DOIs	https://doi.org/10.1093/ije/dyab211
Publication status	Published - 13 Jun 2022

Keywords

MORTALITY
POWDER
RISK

Access to Document

10.1093/ije/dyab211Licence: Other

Full TextFinal published version, 1.63 MBLicence: Taverne

Cite this

Townsend, M. K., Trabert, B., Fortner, R. T., Arslan, A. A., Buring, J. E., Carter, B. D., Giles, G. G., Irvin, S. R., Jones, M. E., Kaaks, R., Kirsh, V. A., Knutsen, S. F., Koh, W.-P., Lacey, J. V., Langseth, H., Larsson, S. C., Lee, I.-M., Martínez, M. E., Merritt, M. A., ... Wentzensen, N. (2022). Cohort Profile: The Ovarian Cancer Cohort Consortium (OC3). International Journal of Epidemiology, 51(3), E73-E86. https://doi.org/10.1093/ije/dyab211

@article{be99a111f03c4161b953420727be00a2,

title = "Cohort Profile: The Ovarian Cancer Cohort Consortium (OC3)",

keywords = "MORTALITY, POWDER, RISK",

author = "Townsend, \{Mary K\} and Britton Trabert and Fortner, \{Ren{\'e}e T\} and Arslan, \{Alan A\} and Buring, \{Julie E\} and Carter, \{Brian D\} and Giles, \{Graham G\} and Irvin, \{Sarah R\} and Jones, \{Michael E\} and Rudolf Kaaks and Kirsh, \{Victoria A\} and Knutsen, \{Synnove F\} and Woon-Puay Koh and Lacey, \{James V\} and Hilde Langseth and Larsson, \{Susanna C\} and I-Min Lee and Mart{\'i}nez, \{Mar{\'i}a Elena\} and Merritt, \{Melissa A\} and Milne, \{Roger L\} and O'Brien, \{Katie M\} and Orlich, \{Michael J\} and Palmer, \{Julie R\} and Patel, \{Alpa V\} and Ulrike Peters and Poynter, \{Jenny N\} and Kim Robien and Rohan, \{Thomas E\} and Lynn Rosenberg and Sven Sandin and Sandler, \{Dale P\} and Schouten, \{Leo J\} and Setiawan, \{V Wendy\} and Swerdlow, \{Anthony J\} and Giske Ursin and \{van den Brandt\}, \{Piet A\} and Kala Visvanathan and Elisabete Weiderpass and Alicja Wolk and Jian-Min Yuan and Anne Zeleniuch-Jacquotte and Tworoger, \{Shelley S\} and Nicolas Wentzensen",

note = "Funding Information: The OC3 received support from the U.S. Department of Defense Ovarian Cancer Research Program (grant numbers W81XWH-12- 1-0561, W81XWH-19-1-0346), National Cancer Institute at the National Institutes of Health (grant numbers R01 CA258679, U01 CA164973) and Intramural Research Program of the National Cancer Institute at the National Institutes of Health. The member studies of the OC3 received support from the: National Cancer Institute at the National Institutes of Health (grant number 1U01CA152939), World Cancer Research Fund (grant number 2009/93) and Ardmore Institute of Health (Adventist Health Study II); American Cancer Society and National Cancer Institute at the National Institutes of Health (Breast Cancer Detection Demonstration Project); National Cancer Institute at the National Institutes of Health (grant numbers P30 CA006973, CA97857, CA86308) (Campaign Against Cancer and Stroke); National Cancer Institute at the National Institutes of Health (grant number R01 CA39742) (Iowa Women's Health Study); National Cancer Institute at the National Institutes of Health (grant number CA164973) (Multiethnic Cohort Study); Intramural Research Program of the National Cancer Institute at the National Institutes of Health (NIH-AARP Diet and Health Study); National Cancer Institute at the National Institutes of Health (grant numbers UM1 CA186107, P01 CA87969, R01 CA49449, UM1 CA176726, R01 CA67262) (Nurses' Health Study and Nurses' Health Study II); National Cancer Institute at the National Institutes of Health (grant numbers UM1 CA182934, P30 CA016087, P30 ES000260) (NYU Women's Health Study); National Cancer Institute at the National Institutes of Health (grant number UM1 CA182876) (Singapore Chinese Health Study); Intramural Research Program of the National Institute of Environmental Health Sciences at the National Institutes of Health (fund number Z01ES044005) (Sister Study); Swedish Research Council (SwedishMammography Cohort); National Cancer Institute and Office of Dietary Supplements at the National Institutes of Health (grant number K05 CA154337) (Vitamins and Lifestyle Study); and National Cancer Institute (grant number CA047988) and National Heart, Lung, and Blood Institute at the National Institutes of Health (grant numbers HL043851, HL080467, HL099355) (The Women's Health Study). The California Teachers Study and the research reported in this publication were supported by National Cancer Institute at the National Institutes of Health (grant numbers U01 CA199277, P30 CA033572, P30 CA023100, UM1 CA164917, R01 CA077398). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. The collection of cancer incidence data used in the California Teachers Study was supported by the: California Department of Public Health pursuant to California Health and Safety Code Section 103885; Centers for Disease Control and Prevention's National Program of Cancer Registries, under cooperative agreement 5NU58DP006344; National Cancer Institute's Surveillance, Epidemiology and End Results Program under contract HHSN261201800032I awarded to the University of California, San Francisco, contract HHSN261201800015I awarded to the University of Southern California and contract HHSN261201800009I awarded to the Public Health Institute. The opinions, findings and conclusions expressed herein are those of the author(s) and do not necessarily reflect the official views of the State of California, Department of Public Health, the National Cancer Institute, National Institutes of Health, Centers for Disease Control and Prevention or their Contractors and Subcontractors, or the Regents of the University of California or any of its programmes. All aspects of the Cancer Prevention Study II were funded by the Intramural Research Program of the American Cancer Society and by the National Cancer Institute at the National Institutes of Health Intramural Research Program. The coordination of the European Prospective Investigation into Cancer and Nutrition (EPIC) is financially supported by the European Commission (DG-SANCO) and the International Agency for Research on Cancer. The national cohorts are supported by the: Danish Cancer Society (Denmark); Ligue Contre le Cancer, Institut Gustave Roussy, Mutuelle G{\'e}n{\'e}rale de l'Education Nationale, Institut National de la Sant{\'e} et de la Recherche M{\'e}dicale (INSERM) (France); German Cancer Aid, German Cancer Research Center (DKFZ), Federal Ministry of Education and Research (BMBF) (Germany); Associazione Italiana per la Ricerca sul Cancro- AIRC-Italy and National Research Council (Italy); Dutch Ministry of Public Health, Welfare and Sports (VWS), Netherlands Cancer Registry (NKR), LK Research Funds, Dutch Prevention Funds, Dutch ZON (Zorg Onderzoek Nederland), World Cancer Research Fund (WCRF), Statistics Netherlands (The Netherlands); Nordforsk (Norway); Health Research Fund (FIS), PI13/00061 to Granada, PI13/ 01162 to EPIC-Murcia, Regional Governments of Andaluc{\'y}a, Asturias, Basque Country, Murcia and Navarra, ISCIII RETIC (RD06/0020) (Spain); Swedish Cancer Society, Swedish Research Council and County Councils of Ska°ne and V{\"a}sterbotten (Sweden); Cancer Research UK (14136 to EPIC-Norfolk; C570/A16491 and C8221/ A19170 to EPIC-Oxford), Medical Research Council (1000143 to EPIC-Norfolk, MR/M012190/1 to EPIC-Oxford) (UK). The Generations Study was supported by Breakthrough Breast Cancer and the Institute of Cancer Research. The Institute for Cancer Research is supported by National Health Service funding to the National Institute for Health Research Biomedical Research Centre. Cohort recruitment for theMelbourne Collaborative Cohort Study (MCCS) was funded by VicHealth and Cancer Council Victoria. The MCCS was further augmented by Australian National Health and Medical Research Council (grant numbers 209057, 396414, 1074383) and by infrastructure provided by Cancer Council Victoria. Cases and their vital status were ascertained through the Victorian Cancer Registry and the Australian Institute of Health and Welfare, including the National Death Index and the Australian Cancer Database. The Swedish Women's Lifestyle and Health Study was supported by the Swedish Cancer Society and Swedish Research Council. Where authors are identified as personnel of the International Agency for Research on Cancer/World Health Organization, the authors alone are responsible for the views expressed in this article and they do not necessarily represent the decisions, policy or views of the International Agency for Research on Cancer/World Health Organization.",

year = "2022",

month = jun,

day = "13",

doi = "10.1093/ije/dyab211",

language = "English",

volume = "51",

pages = "E73--E86",

journal = "International Journal of Epidemiology",

issn = "0300-5771",

publisher = "Oxford University Press",

number = "3",

}

Townsend, MK, Trabert, B, Fortner, RT, Arslan, AA, Buring, JE, Carter, BD, Giles, GG, Irvin, SR, Jones, ME, Kaaks, R, Kirsh, VA, Knutsen, SF, Koh, W-P, Lacey, JV, Langseth, H, Larsson, SC, Lee, I-M, Martínez, ME, Merritt, MA, Milne, RL, O'Brien, KM, Orlich, MJ, Palmer, JR, Patel, AV, Peters, U, Poynter, JN, Robien, K, Rohan, TE, Rosenberg, L, Sandin, S, Sandler, DP, Schouten, LJ, Setiawan, VW, Swerdlow, AJ, Ursin, G, van den Brandt, PA, Visvanathan, K, Weiderpass, E, Wolk, A, Yuan, J-M, Zeleniuch-Jacquotte, A, Tworoger, SS & Wentzensen, N 2022, 'Cohort Profile: The Ovarian Cancer Cohort Consortium (OC3)', International Journal of Epidemiology, vol. 51, no. 3, pp. E73-E86. https://doi.org/10.1093/ije/dyab211

TY - JOUR

T1 - Cohort Profile

T2 - The Ovarian Cancer Cohort Consortium (OC3)

AU - Townsend, Mary K

AU - Trabert, Britton

AU - Fortner, Renée T

AU - Arslan, Alan A

AU - Buring, Julie E

AU - Carter, Brian D

AU - Giles, Graham G

AU - Irvin, Sarah R

AU - Jones, Michael E

AU - Kaaks, Rudolf

AU - Kirsh, Victoria A

AU - Knutsen, Synnove F

AU - Koh, Woon-Puay

AU - Lacey, James V

AU - Langseth, Hilde

AU - Larsson, Susanna C

AU - Lee, I-Min

AU - Martínez, María Elena

AU - Merritt, Melissa A

AU - Milne, Roger L

AU - O'Brien, Katie M

AU - Orlich, Michael J

AU - Palmer, Julie R

AU - Patel, Alpa V

AU - Peters, Ulrike

AU - Poynter, Jenny N

AU - Robien, Kim

AU - Rohan, Thomas E

AU - Rosenberg, Lynn

AU - Sandin, Sven

AU - Sandler, Dale P

AU - Schouten, Leo J

AU - Setiawan, V Wendy

AU - Swerdlow, Anthony J

AU - Ursin, Giske

AU - van den Brandt, Piet A

AU - Visvanathan, Kala

AU - Weiderpass, Elisabete

AU - Wolk, Alicja

AU - Yuan, Jian-Min

AU - Zeleniuch-Jacquotte, Anne

AU - Tworoger, Shelley S

AU - Wentzensen, Nicolas

N1 - Funding Information: The OC3 received support from the U.S. Department of Defense Ovarian Cancer Research Program (grant numbers W81XWH-12- 1-0561, W81XWH-19-1-0346), National Cancer Institute at the National Institutes of Health (grant numbers R01 CA258679, U01 CA164973) and Intramural Research Program of the National Cancer Institute at the National Institutes of Health. The member studies of the OC3 received support from the: National Cancer Institute at the National Institutes of Health (grant number 1U01CA152939), World Cancer Research Fund (grant number 2009/93) and Ardmore Institute of Health (Adventist Health Study II); American Cancer Society and National Cancer Institute at the National Institutes of Health (Breast Cancer Detection Demonstration Project); National Cancer Institute at the National Institutes of Health (grant numbers P30 CA006973, CA97857, CA86308) (Campaign Against Cancer and Stroke); National Cancer Institute at the National Institutes of Health (grant number R01 CA39742) (Iowa Women's Health Study); National Cancer Institute at the National Institutes of Health (grant number CA164973) (Multiethnic Cohort Study); Intramural Research Program of the National Cancer Institute at the National Institutes of Health (NIH-AARP Diet and Health Study); National Cancer Institute at the National Institutes of Health (grant numbers UM1 CA186107, P01 CA87969, R01 CA49449, UM1 CA176726, R01 CA67262) (Nurses' Health Study and Nurses' Health Study II); National Cancer Institute at the National Institutes of Health (grant numbers UM1 CA182934, P30 CA016087, P30 ES000260) (NYU Women's Health Study); National Cancer Institute at the National Institutes of Health (grant number UM1 CA182876) (Singapore Chinese Health Study); Intramural Research Program of the National Institute of Environmental Health Sciences at the National Institutes of Health (fund number Z01ES044005) (Sister Study); Swedish Research Council (SwedishMammography Cohort); National Cancer Institute and Office of Dietary Supplements at the National Institutes of Health (grant number K05 CA154337) (Vitamins and Lifestyle Study); and National Cancer Institute (grant number CA047988) and National Heart, Lung, and Blood Institute at the National Institutes of Health (grant numbers HL043851, HL080467, HL099355) (The Women's Health Study). The California Teachers Study and the research reported in this publication were supported by National Cancer Institute at the National Institutes of Health (grant numbers U01 CA199277, P30 CA033572, P30 CA023100, UM1 CA164917, R01 CA077398). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. The collection of cancer incidence data used in the California Teachers Study was supported by the: California Department of Public Health pursuant to California Health and Safety Code Section 103885; Centers for Disease Control and Prevention's National Program of Cancer Registries, under cooperative agreement 5NU58DP006344; National Cancer Institute's Surveillance, Epidemiology and End Results Program under contract HHSN261201800032I awarded to the University of California, San Francisco, contract HHSN261201800015I awarded to the University of Southern California and contract HHSN261201800009I awarded to the Public Health Institute. The opinions, findings and conclusions expressed herein are those of the author(s) and do not necessarily reflect the official views of the State of California, Department of Public Health, the National Cancer Institute, National Institutes of Health, Centers for Disease Control and Prevention or their Contractors and Subcontractors, or the Regents of the University of California or any of its programmes. All aspects of the Cancer Prevention Study II were funded by the Intramural Research Program of the American Cancer Society and by the National Cancer Institute at the National Institutes of Health Intramural Research Program. The coordination of the European Prospective Investigation into Cancer and Nutrition (EPIC) is financially supported by the European Commission (DG-SANCO) and the International Agency for Research on Cancer. The national cohorts are supported by the: Danish Cancer Society (Denmark); Ligue Contre le Cancer, Institut Gustave Roussy, Mutuelle Générale de l'Education Nationale, Institut National de la Santé et de la Recherche Médicale (INSERM) (France); German Cancer Aid, German Cancer Research Center (DKFZ), Federal Ministry of Education and Research (BMBF) (Germany); Associazione Italiana per la Ricerca sul Cancro- AIRC-Italy and National Research Council (Italy); Dutch Ministry of Public Health, Welfare and Sports (VWS), Netherlands Cancer Registry (NKR), LK Research Funds, Dutch Prevention Funds, Dutch ZON (Zorg Onderzoek Nederland), World Cancer Research Fund (WCRF), Statistics Netherlands (The Netherlands); Nordforsk (Norway); Health Research Fund (FIS), PI13/00061 to Granada, PI13/ 01162 to EPIC-Murcia, Regional Governments of Andalucýa, Asturias, Basque Country, Murcia and Navarra, ISCIII RETIC (RD06/0020) (Spain); Swedish Cancer Society, Swedish Research Council and County Councils of Ska°ne and Västerbotten (Sweden); Cancer Research UK (14136 to EPIC-Norfolk; C570/A16491 and C8221/ A19170 to EPIC-Oxford), Medical Research Council (1000143 to EPIC-Norfolk, MR/M012190/1 to EPIC-Oxford) (UK). The Generations Study was supported by Breakthrough Breast Cancer and the Institute of Cancer Research. The Institute for Cancer Research is supported by National Health Service funding to the National Institute for Health Research Biomedical Research Centre. Cohort recruitment for theMelbourne Collaborative Cohort Study (MCCS) was funded by VicHealth and Cancer Council Victoria. The MCCS was further augmented by Australian National Health and Medical Research Council (grant numbers 209057, 396414, 1074383) and by infrastructure provided by Cancer Council Victoria. Cases and their vital status were ascertained through the Victorian Cancer Registry and the Australian Institute of Health and Welfare, including the National Death Index and the Australian Cancer Database. The Swedish Women's Lifestyle and Health Study was supported by the Swedish Cancer Society and Swedish Research Council. Where authors are identified as personnel of the International Agency for Research on Cancer/World Health Organization, the authors alone are responsible for the views expressed in this article and they do not necessarily represent the decisions, policy or views of the International Agency for Research on Cancer/World Health Organization.

PY - 2022/6/13

Y1 - 2022/6/13

KW - MORTALITY

KW - POWDER

KW - RISK

U2 - 10.1093/ije/dyab211

DO - 10.1093/ije/dyab211

M3 - Article

C2 - 34652432

SN - 0300-5771

VL - 51

SP - E73-E86

JO - International Journal of Epidemiology

JF - International Journal of Epidemiology

IS - 3

ER -